Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Note: Phase 3 trial counts may underestimate recent activity due to registration lag
Designed for adults with obesity or overweight individuals with weight-related complications, this oral option mimics natural hormones to regulate appetite and reduce cravings
Our program is specifically designed for the resident looking for an effective Michigan Wegovy and Zepbound program
A thorough clinical assessment is essential to differentiate between medication-related effects, consequences of weight loss and lifestyle modification, and independent medical conditions requiring specific intervention
The SURMOUNT trials showed tirzepatide at 15 mg producing over 22% body weight loss on average, compared to roughly 15% for semaglutide 2.4 mg in the STEP trials
Fast approval means you get your medication sooner
US$ 26.31
US$ 24.43
US$ 20.35
US$ 23.15
US$ 22.05
US$ 26.75
